REGISTERED
on 17 Mar 2020
Last Applicant/ Owned by
53 Seonggogae-ro,
Uiwang-si
KR
Gyeonggi-
Serial Number
88272166 filed on 23rd Jan 2019
Registration Number
6011037 registered on 17th Mar 2020
Correspondent Address
John Alumit
Filing Basis
No Filing Basis
Disclaimer
NO DATA
CHERRYSENS
Diagnostic preparations for medical purposes; Disinfectants; Medical diagnostic reagents; Medical diagnostic test strips for use in the field of smoking treatment; Medical diagnostic test strips for use in the field of blood related disease; Pharmaceutical preparations for treating diabetes; Smoking cessation preparations; Sterilizing preparations; Test strips for measuring blood glucose levels
Classification Information
Class [005]
Pharmaceutical Products
Diagnostic preparations for medical purposes; Disinfectants; Medical diagnostic reagents; Medical diagnostic test strips for use in the field of smoking treatment; Medical diagnostic test strips for use in the field of blood related disease; Pharmaceutical preparations for treating diabetes; Smoking cessation preparations; Sterilizing preparations; Test strips for measuring blood glucose levels
Mark Details
Serial Number
No 88272166
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
05.03.25 -
Other leaves
05.09.08 -
Cherries
26.09.21 -
Squares that are completely or partially shaded
Legal History
| Status Date | Action Taken |
|---|---|
| 17th Mar 2020 | REGISTERED-PRINCIPAL REGISTER |
| 31st Dec 2019 | PUBLISHED FOR OPPOSITION |
| 31st Dec 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 11th Dec 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 21st Nov 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 21st Nov 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 21st Nov 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 20th Nov 2019 | ASSIGNED TO LIE |
| 12th Nov 2019 | ASSIGNED TO LIE |
| 04th Nov 2019 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |